Aspirin is associated with improved outcomes in patients with sepsis-induced myocardial injury: An analysis of the MIMIC-IV database
Yiming Dong,
No information about this author
Shuxing Wei,
No information about this author
阳 刘
No information about this author
et al.
Journal of Clinical Anesthesia,
Journal Year:
2024,
Volume and Issue:
99, P. 111597 - 111597
Published: Sept. 7, 2024
Language: Английский
Aspirin is associated with improved 30-day mortality in patients with sepsis-associated liver injury: a retrospective cohort study based on MIMIC IV database
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 4, 2025
Background
Sepsis-associated
liver
injury
(SALI)
is
a
common
complication
in
sepsis
patients,
significantly
affecting
their
prognosis.
Previous
studies
have
shown
that
aspirin
can
improve
the
prognosis
of
septic
patients.
However,
there
currently
lack
clinical
evidence
supporting
use
treatment
SALI.
Therefore,
we
conducted
this
study
to
explore
association
between
and
patients
with
Methods
The
were
obtained
from
Medical
Information
Mart
for
Intensive
Care
IV
(MIMIC-IV)
database,
version
3.0.
primary
outcome
was
30-day
all-cause
mortality.
Baseline
characteristics
non-aspirin
groups
balanced
using
propensity
score
matching
(PSM).
Kaplan-Meier
survival
curve
Cox
regression
analysis
used
investigate
Results
Of
657
SALI
study,
447
(68%)
had
not
during
hospitalization,
whereas
210
(32%)
had.
After
PSM,
mortality
33.1%
group
21%
group,
indicating
reduced
risk
(HR,
0.57;
95%
CI,
0.37–0.90;
P
=
0.016).
Similarly,
results
multivariable
inverse
probability
weighting
(IPW)
showed
that,
compared
lower
(Multivariable
analysis:
HR,
0.69;
0.48–0.99;
0.047;
IPW:
0.62;
0.43–0.89;
0.010).
Conclusion
Aspirin
reduce
regardless
dose
or
timing
administration.
careful
assessment
based
on
individual
differences
essential
ensure
safety
effectiveness
use.
Language: Английский
Investigating the role of aspirin on the mortality risk of sepsis-associated encephalopathy: a retrospective study
Fengzhen Huang,
No information about this author
Jiping Yi,
No information about this author
Qiuli Li
No information about this author
et al.
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 26, 2025
Background
Sepsis-associated
encephalopathy
(SAE)
is
one
of
the
most
common
complications
sepsis.
Aspirin
can
serve
as
a
promising
therapeutic
candidate
and
help
improve
patient
outcomes
in
sepsis
its
complications.
However,
efficacy
safety
aspirin
on
SAE
remains
largely
unexplored.
Methods
Patients
for
this
retrospective
study
were
collected
from
MIMIC-IV
(version
3.0).
Propensity
score
matching
(PSM)
was
used
to
balance
baseline
characteristics
between
no
group
group.
The
association
therapy
mortality
risk
in-hospital,
30-day,
60-day,
90-day,
180-day
analyzed
by
Cox
proportional
hazards
model
Kaplan–Meier
method.
E
-value
analysis
evaluate
potential
influence
unmeasured
or
unknown
confounding
factors.
Subgroup
applied
explore
differences
effects
clinical
across
these
various
groups.
Results
Our
recruited
4,707
patients
total,
2,518
enrolled
after
PSM.
rate
consistently
significant
lower
than
that
curves
revealed
received
exhibited
notably
higher
survival
compared
those
who
did
not.
gastrointestinal
hemorrhage
had
difference
two
Additionally,
pre-ICU
group,
in-ICU
decreased
significantly
high-dose
experienced
low-dose
Conclusion
could
reduce
180-day,
without
increasing
hemorrhage.
benefits
observed
persisted
regardless
exposure
timing.
Language: Английский
Metabolic syndrome induces benefits in mice experiencing severe sepsis, comparable to the effects of low-dose aspirin pretreatment in septic mice lacking metabolic syndrome
Raquel Pires Nakama,
No information about this author
Lucas Felipe dos Santos,
No information about this author
Leonardo Berto-Pereira
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
139, P. 112694 - 112694
Published: July 17, 2024
Language: Английский
Incidence and predictors of acute kidney injury after elective surgery for lumbar degenerative disease: A 13-year analysis of the US Nationwide Inpatient Sample
Journal of the Chinese Medical Association,
Journal Year:
2024,
Volume and Issue:
87(4), P. 400 - 409
Published: Feb. 9, 2024
Background:
Acute
kidney
injury
(AKI)
is
a
severe
postoperative
complication
associated
with
poor
clinical
outcomes,
including
the
development
of
chronic
disease
(CKD)
and
death.
This
study
aimed
to
investigate
incidence
determinants
AKI
following
elective
surgeries
for
degenerative
lumbar
spine
disease.
Methods:
All
patient
data
were
extracted
from
US
Nationwide
Inpatient
Sample
database.
After
surgery,
AKI’s
risk
factors
identified
ICD-9
ICD-10
codes
defined
disease,
fusion,
decompression,
AKI.
The
cohort
was
categorized
by
type
that
is,
decompression
alone
or
spinal
fusion.
Regression
analysis
used
identify
associations
between
organized
surgery
type.
Results:
after
fusion
1.1%
1.8%,
respectively.
However,
in
United
States
rising.
strongest
predictor
underlying
CKD,
which
an
9.0-
12.9-fold
more
significant
than
subjects
without
comorbid
CKD.
In
this
setting,
older
age,
congestive
heart
failure,
anemia,
obesity,
coagulopathy
hospital-acquired
infections
also
strong
predictors
contrast,
long-term
aspirin/anticoagulant
usage
lowered
risk.
Conclusion:
Findings
inform
stratification
may
help
optimize
treatment
decisions
care
planning
Language: Английский
Impact of dexmedetomidine on mortality in critically ill patients with acute kidney injury: a retrospective propensity score matching analysis
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(11), P. e073675 - e073675
Published: Nov. 1, 2023
Objectives
This
study
sought
to
estimate
the
effect
of
dexmedetomidine
(DEX)
administration
on
mortality
in
critically
ill
patients
with
acute
kidney
injury
(AKI).
Design
A
retrospective
cohort
study.
Setting
The
sourced
its
data
from
Multiparameter
Intelligent
Monitoring
Intensive
Care
Database
IV
(MIMIC-IV),
a
comprehensive
database
intensive
care
unit
patients.
Participants
total
15
754
AKI
were
enrolled
MIMIC-IV
database.
Primary
and
secondary
outcome
was
in-hospital
180-day
mortality.
Results
included
our
analysis.
We
found
that
DEX
use
decreased
risk
by
38%
(HR
0.62,
95%
CI
0.55
0.70)
23%
0.77,
0.69
0.85).
After
adjusting
for
confounding
factors,
can
reduce
all
three
stages
Conclusions
Our
suggests
significantly
correlates
risk-adjusted
Nonetheless,
future
randomised
controlled
trials
are
warranted
validate
findings.
Language: Английский